Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-12 06:04 am Purchase | 2026-11-09 | 13D | PDS BIOTECHNOLOGY CORP COM PDSB | Nant Capital, LLC | 22,856,453 19.900% | 2,520,118 (+12.39%) | Filing History |
| 2026-09-21 9:56 pm Purchase | 2026-09-14 | 13D | PDS BIOTECHNOLOGY CORP COM PDSB | Nant Capital, LLC | 20,336,335 19.900% | 20,336,335 (New Position) | Filing History |
| 2025-08-14 8:52 pm Sale | 2025-06-30 | 13G | PDS BIOTECHNOLOGY CORP COM PDSB | Armistice Capital, LLC | 2,283,288 4.990% | -2,264,637 (-49.79%) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | PDS BIOTECHNOLOGY CORP COM PDSB | Armistice Capital, LLC | 4,547,925 9.990% | 4,547,925 (New Position) | Filing History |
| 2024-05-08 2:22 pm Sale | 2024-04-30 | 13G | PDS BIOTECHNOLOGY CORP COM PDSB | BlackRock Inc. BLK | 1,821,621 4.960% | -59,817 (-3.18%) | Filing History |
| 2024-01-29 5:26 pm Purchase | 2023-12-31 | 13G | PDS BIOTECHNOLOGY CORP COM PDSB | BlackRock Inc. BLK | 1,881,438 6.000% | 1,881,438 (New Position) | Filing History |